Mangalam Drugs & Organics Limited (MANGALAM) Share Price & AI Investment Analysis

Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers active pharmaceutical ingredients (API) products, including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, etodolac, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, olanzapine, primaquine and piperaquine phosphate, pyrimethamine, pyronaridine tetrapho. Track Mangalam Drugs & Organics Limited's live NSE:MANGALAM share price ₹32.32 (+0.25%), market cap ₹₹51Cr. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for MANGALAM — real-time NSE India stock intelligence.